BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34085362)

  • 1. The role of psychosocial factors in Black women's self-efficacy in receiving genetic counseling and testing.
    Ding H; Sutton AL; Hurtado-de-Mendoza A; Sheppard VB
    J Genet Couns; 2021 Dec; 30(6):1719-1726. PubMed ID: 34085362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black Women's Confidence in the Genetic Information Nondiscrimination Act.
    Sutton AL; Henderson A; Hurtado-de-Mendoza A; Tanner E; Khan M; Quillin J; Sheppard VB
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.
    Hurtado-de-Mendoza A; Jackson MC; Anderson L; Sheppard VB
    J Genet Couns; 2017 Feb; 26(1):113-121. PubMed ID: 27402168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
    Sheppard VB; Mays D; LaVeist T; Tercyak KP
    J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods.
    Sheppard VB; Sutton AL; Hurtado-De-Mendoza A; Tariq F; Perera RA; Quillin J; Jeudy M; Gómez-Trillos S; Schwartz MD
    Contemp Clin Trials; 2023 Jul; 130():107210. PubMed ID: 37142159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    Ademuyiwa FO; Salyer P; Tao Y; Luo J; Hensing WL; Afolalu A; Peterson LL; Weilbaecher K; Housten AJ; Baumann AA; Desai M; Jones S; Linnenbringer E; Plichta J; Bierut L
    J Clin Oncol; 2021 Dec; 39(36):4020-4028. PubMed ID: 34662201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Medical Mistrust in Black Women at Risk of BRCA 1/2 Mutations.
    Sutton AL; He J; Tanner E; Edmonds MC; Henderson A; Hurtado de Mendoza A; Sheppard VB
    J Health Dispar Res Pract; 2019; 12(3):35-47. PubMed ID: 32995070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.
    Sussner KM; Thompson HS; Jandorf L; Edwards TA; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
    Psychooncology; 2009 Sep; 18(9):945-55. PubMed ID: 19090507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.
    Thompson HS; Sussner K; Schwartz MD; Edwards T; Forman A; Jandorf L; Brown K; Bovbjerg DH; Valdimarsdottir HB
    Genet Test Mol Biomarkers; 2012 Nov; 16(11):1257-62. PubMed ID: 23057569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A culturally targeted video to promote genetic counseling in a community sample of at-risk US Latina women: The role of the concrete mindset.
    Carrera P; Sheppard VB; Caballero A; Gómez-Trillos S; Hurtado-de-Mendoza A
    J Community Psychol; 2022 Apr; 50(3):1331-1342. PubMed ID: 34606624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
    Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
    J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
    An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
    Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
    Armstrong K; Micco E; Carney A; Stopfer J; Putt M
    JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer.
    Halbert Ch; Kessler L; Collier A; Paul Wileyto E; Brewster K; Weathers B
    Clin Genet; 2005 Sep; 68(3):222-7. PubMed ID: 16098010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.
    Bowen A; Gómez-Trillos S; Curran G; Graves KD; Sheppard VB; Schwartz MD; Peshkin BN; Campos C; Garcés N; Dash C; Aburto L; Valencia-Rojas N; Hernández G; Villa A; Cupertino P; Carrera P; Hurtado-de-Mendoza A
    J Genet Couns; 2023 Oct; 32(5):965-981. PubMed ID: 37062905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial impact of BRCA testing in young Black breast cancer survivors.
    Gonzalez BD; Hoogland AI; Kasting ML; Cragun D; Kim J; Ashing K; Holt CL; Hughes Halbert C; Pal T; Vadaparampil ST
    Psychooncology; 2018 Dec; 27(12):2778-2785. PubMed ID: 30207419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City.
    Sussner KM; Edwards TA; Thompson HS; Jandorf L; Kwate NO; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
    Public Health Genomics; 2011; 14(6):356-70. PubMed ID: 21540561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
    Durfy SJ; Bowen DJ; McTiernan A; Sporleder J; Burke W
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):369-75. PubMed ID: 10207642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.